VICTORY CAPITAL MANAGEMENT INC - APELLIS PHARMACEUTICALS INC ownership

APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 188 filers reported holding APELLIS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
VICTORY CAPITAL MANAGEMENT INC ownership history of APELLIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$28,092,959
-23.1%
738,511
+84.2%
0.03%
-20.0%
Q2 2023$36,527,182
-1.5%
400,957
-28.7%
0.04%
-4.8%
Q1 2023$37,080,667
+66.6%
562,169
+30.6%
0.04%
+61.5%
Q4 2022$22,263,793
-51.6%
430,551
-36.0%
0.03%
-51.9%
Q3 2022$45,970,000
+45.6%
673,051
-3.6%
0.05%
+50.0%
Q2 2022$31,572,000
-53.0%
698,171
-47.3%
0.04%
-46.3%
Q1 2022$67,235,000
-9.2%
1,324,964
-15.4%
0.07%
-1.5%
Q4 2021$74,040,000
+26.9%
1,565,977
-11.6%
0.07%
+19.3%
Q3 2021$58,366,000
-44.2%
1,770,807
+6.9%
0.06%
-43.0%
Q2 2021$104,677,000
+26.1%
1,656,288
-14.3%
0.10%
+17.6%
Q1 2021$82,979,000
-24.0%
1,933,780
+1.2%
0.08%
-30.3%
Q4 2020$109,251,000
+68.8%
1,909,977
-11.0%
0.12%
+47.0%
Q3 2020$64,728,000
+0.9%
2,145,462
+9.2%
0.08%
-4.6%
Q2 2020$64,162,000
-35.8%
1,964,545
-47.4%
0.09%
+3.6%
Q1 2020$100,004,000
+50.5%
3,732,830
+72.1%
0.08%
+3.7%
Q4 2019$66,426,000
+53.1%
2,169,349
+20.4%
0.08%
+44.6%
Q3 2019$43,397,000
+3.0%
1,801,442
+8.4%
0.06%
-34.1%
Q2 2019$42,120,000
+27.9%
1,662,203
-1.6%
0.08%
+13.3%
Q1 2019$32,929,000
+79.9%
1,688,663
+21.7%
0.08%
+63.0%
Q4 2018$18,305,000
-23.6%
1,387,763
+3.0%
0.05%
-6.1%
Q3 2018$23,963,000
+16.8%
1,347,753
+44.5%
0.05%
+11.4%
Q2 2018$20,520,000
+148.9%
932,753
+150.2%
0.04%
+144.4%
Q1 2018$8,243,000372,8400.02%
Other shareholders
APELLIS PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 3,130,000$119,065,20018.29%
EcoR1 Capital, LLC 10,899,859$414,630,63613.99%
Ally Bridge Group (NY) LLC 181,805$6,915,8628.12%
Avoro Capital Advisors LLC 11,111,111$422,666,6626.59%
ACUTA CAPITAL PARTNERS, LLC 244,484$9,300,1716.23%
Iron Triangle Partners LP 880,000$33,475,2004.89%
Cormorant Asset Management, LP 2,000,000$76,080,0004.44%
Octagon Capital Advisors LP 675,000$25,677,0003.94%
Logos Global Management LP 750,000$28,530,0003.81%
Boxer Capital, LLC 1,726,000$65,657,0403.50%
View complete list of APELLIS PHARMACEUTICALS INC shareholders